Prospective Registry of Histotripsy for Soft Tissue Tumors

StatusEnrolling by Invitation
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Recruiting → Enrolling by Invitation
    • Eligibility criteria expanded, about 11 words
    • Study description expanded, about 13 words
    • Site details revised
  2. Primary endpoints revised (4)v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.
Trial Details
NCT Number NCT07470008
Lead Sponsor University of California, San Francisco
Conditions
(from sponsor)		 Soft Tissue Neoplasm, Soft Tissue Cancer, Soft Tissue Lesion
Related terms Sarcoma, Soft Tissue Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov